Zim Laboratories Quarterly Results for Trading Insights
ZIMLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QSept 2025
Zim Laboratories Quarterly Results Key Highlights
- Revenue of ₹91 Cr in Sept 2025 (-17.3% vs Mar 2025, -3.2% vs Sept 2024)
- EBITDA of ₹8 Cr in Sept 2025 (-50.0% vs Mar 2025)
- Operating Margin of 6.0% in Sept 2025 (-7.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.09 in Sept 2025 (-108.9% vs Mar 2025)
Zim Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 91 | 110 | 73 | 94 | 119 | -17.3% | -3.2% |
| Net Profit (₹ Cr) | 0 | 5 | -2 | 2 | 8 | - | - |
| EBITDA (₹ Cr) | 8 | 16 | 6 | 11 | 17 | - | - |
| EPS (₹) | -0.09 | 1.01 | -0.38 | 0.49 | 1.66 | - | - |
| Operating Margin (%) | 6.0% | 13.0% | 6.0% | 10.0% | 13.0% | - | - |
Zim Laboratories Share Price Trend Around Quarterly Results
Visualize Zim Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Zim Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Zim Laboratories
Additional stock information and data for ZIMLAB
Revenue Trend (₹ Cr)
Sept 2024
94
Jun 2025
73
Mar 2025
110
Sept 2025
91
Net Profit Trend (₹ Cr)
Sept 2024
2
Jun 2025
-2
Mar 2025
5
Sept 2025
0
Operating Margin Trend (%)
Sept 2024
10.0%
Jun 2025
6.0%
Mar 2025
13.0%
Sept 2025
6.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Zim Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹429,456.97 Cr | 1812.8 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6372.0 | 2,860 | 689 | +7.1% | - | 24.1% | 245.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4427.8 | 3,219 | 591 | +11.3% | - | 18.4% | 252.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,416.93 Cr | 1314.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1333.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores